136 related articles for article (PubMed ID: 33465429)
21. Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma.
Moncrieff MD; O'Leary FM; Beadsmoore CJ; Pawaroo D; Heaton MJ; Isaksson K; Olofsson Bagge R
Br J Surg; 2020 May; 107(6):669-676. PubMed ID: 32077090
[TBL] [Abstract][Full Text] [Related]
22. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
[TBL] [Abstract][Full Text] [Related]
23. Is sentinel lymph node biopsy of therapeutic relevance for melanoma?
Möhrle M; Schippert W; Rassner G; Garbe C; Breuninger H
Dermatology; 2004; 209(1):5-13. PubMed ID: 15237261
[TBL] [Abstract][Full Text] [Related]
24. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
25. Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free.
Wasserberg N; Tulchinsky H; Schachter J; Feinmesser M; Gutman H
Eur J Surg Oncol; 2004 Oct; 30(8):851-6. PubMed ID: 15336731
[TBL] [Abstract][Full Text] [Related]
26. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
[TBL] [Abstract][Full Text] [Related]
27. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
[TBL] [Abstract][Full Text] [Related]
28. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
29. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
Bello DM; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):938-945. PubMed ID: 27527717
[TBL] [Abstract][Full Text] [Related]
30. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck.
Fincher TR; O'Brien JC; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; Kuhn JA
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):844-8. PubMed ID: 15262761
[TBL] [Abstract][Full Text] [Related]
31. Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging.
Murtha TD; Han G; Han D
Ann Surg Oncol; 2018 Apr; 25(4):903-911. PubMed ID: 29368153
[TBL] [Abstract][Full Text] [Related]
32. The role of sentinel lymph node biopsy in the management of head and neck desmoplastic melanoma.
Mohebati A; Ganly I; Busam KJ; Coit D; Kraus DH; Shah JP; Patel SG
Ann Surg Oncol; 2012 Dec; 19(13):4307-13. PubMed ID: 22766985
[TBL] [Abstract][Full Text] [Related]
33. Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.
Nelson DW; Stern S; Elashoff DE; Elashoff R; Thompson JF; Mozzillo N; Nieweg OE; Hoekstra HJ; Cochran AJ; Faries MB
J Am Coll Surg; 2017 Aug; 225(2):302-311. PubMed ID: 28668274
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
35. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
Fritsch VA; Cunningham JE; Lentsch EJ
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
[TBL] [Abstract][Full Text] [Related]
36. Single-stage excision and sentinel lymph node biopsy in cutaneous melanoma in selected patients: a retrospective case-control study.
Giudice G; Robusto F; Vestita M; Annoscia P; Elia R; Nacchiero E
Melanoma Res; 2017 Dec; 27(6):573-579. PubMed ID: 28574976
[TBL] [Abstract][Full Text] [Related]
37. Sentinel lymph node biopsy in melanoma: controversies and current guidelines.
Durham AB; Wong SL
Future Oncol; 2014 Feb; 10(3):429-42. PubMed ID: 24559449
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
39. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
[TBL] [Abstract][Full Text] [Related]
40. Treatment and outcomes of melanoma with a Breslow's depth greater than or equal to one millimeter in a regional teaching hospital.
Scott JD; McKinley BP; Bishop A; Trocha SD
Am Surg; 2005 Mar; 71(3):198-201. PubMed ID: 15869131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
